Literature DB >> 21409955

Cellular and molecular mechanisms of cancer cell invasion.

O De Wever1, L Lapeire, A De Boeck, A Hendrix.   

Abstract

Cancer malignancy is characterized by cancer cell invasion within local and distant ecosystems. Data from our laboratory are reviewed with a focus on cross-signaling between cancer cells and host cells such as myofibroblasts, mesenchymal stem cells and adipocytes. Invasion-associated cellular activities, namely epithelial to mesenchymal transition, homotypic and heterotypic cell-cell adhesion, cell-matrix adhesion, migration, proteolysis and vesicle exocytosis, depend on branching networks of signal transduction pathways including activation of trimeric G proteins, phosphoinositide 3-kinase, src, signal transducer and activator of transcription and the Rab, Rac and Rho family of small GTPases. The role of proteolysis in invasion is not limited to breakdown of extracellular matrix but also causes cleavage of pro-angiogenic fragments from cell surface glycoproteins. Some cell types or molecules implicated in invasion-associated activities may serve as prognostic biomarker or as target for patient-tailored therapy.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21409955

Source DB:  PubMed          Journal:  Verh K Acad Geneeskd Belg        ISSN: 0302-6469


  3 in total

1.  The Stromal Overexpression of CD10 in Invasive Breast Cancer and its Association with Clincophathologic Factors.

Authors:  Ali Taghizadeh-Kermani; Amir Hossein Jafarian; Reza Ashabyamin; Mehdi Seilanian-Toosi; Leila Pourali; Mehdi Asadi; Leila Mashhadi
Journal:  Iran J Cancer Prev       Date:  2014

2.  Stromal CD10 expression in gastric adenocarcinoma.

Authors:  Sara Jalal Aziz; Jalal Ali Jalal; Kalthuma Saleh Hamadameen
Journal:  J Med Life       Date:  2022-05

3.  Epithelial-to-mesenchymal transition in pancreatic ductal adenocarcinoma and pancreatic tumor cell lines: the role of neutrophils and neutrophil-derived elastase.

Authors:  Thomas Grosse-Steffen; Thomas Giese; Nathalia Giese; Thomas Longerich; Peter Schirmacher; G Maria Hänsch; Matthias M Gaida
Journal:  Clin Dev Immunol       Date:  2012-11-20
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.